22-May-17 Singapore eDevelopment has initiated research on a new universal therapeutic drug platform, known as Linebacker, to combat a range of diseases including Alzheimer's, diabetes and cancer. The research will be led by two-time Nobel Prize nominee Daryl Thompson. [image: ET Healthworld / BBCL]

22-May-17 A study carried out in Latin American countries concluded that most efforts of the health system concentrate on the higher income population while neglecting the needs of the lower income classes, driven by the high cost of drugs. [image: Global Health Intelligence]

17-May-17 As Asia develops, many countries are gaining the skills, capital and desire to be part of an unfolding genomics revolution. Recent advances are allowing us to screen for previously hidden disease risks and develop personalized treatments. [image: Wikimedia Commons / Scotted 400]

19-May-17 There are about 550 mn people in India who have uncorrected refractive error. The economic impact translates to about INR2 tn (USD31 bn) loss of productivity, according to Saugata Banerjee, Vice President 2.5 NVG. [image: ET Healthworld]

Share

Latest

About us

GGM is a research and advisory firm helping clients grow profitably in international markets.

We believe the only way to understand a market properly is on the ground. Intelligence from our in-country consultants gives you a competitive advantage in China, Asia, Latin America, the Middle East, Africa and other opportunity areas.

Our clients benefit from accurate data, reliable insights and strategic advice, giving them the confidence to make better business decisions and succeed in their global growth markets.

Stay informed

Enter your work email to receive our free GROW newsletter on international market intelligence and strategy.